Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Development of masked therapeutic antibodies to limit off-target effects: application to anti-EGFR antibodies

Development of masked therapeutic antibodies to limit off-target effects: application to anti-EGFR antibodies

US Patent 11186642 · Granted Nov 30, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Activatable masked anti-CTLA4 binding proteins2025
Anti-CD6 antibody-growth factor complex for treating autoimmune diseases2025
Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy2024
Multi-specific ligand binders2024
CTLA4-binding protein peptide-linker masks2024
CTLA4-binding protein peptide-linker masks2024
Mechanically interlocking complexes2024
Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy2023
Development of masked therapeutic antibodies to limit off-target effects2022
Development of masked therapeutic antibodies to limit off-target effects2022
Development of masked therapeutic antibodies to limit off-target effects2022
Development of masked therapeutic antibodies to limit off-target effects2022